View Older Stories View More Recent Stories

May 30, 2025 07:54AM Summit Therapeutics (SMMT): Ivonescimab Plus Chemo Demonstrates Statistically Significant and Clinically Meaningful Improvement in PFS in Patients with EGFR-Mutant NSCLC
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 28, 2025 04:25AM Citizens JMP shares updates on cancer treatment stocks
May 22, 2025 12:33AM Clear Street Starts Summit Therapeutics plc (SMMT) at Buy
May 8, 2025 05:29AM TD Cowen Upgrades Summit Therapeutics plc (SMMT) to Buy
May 2, 2025 10:18AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
May 1, 2025 04:10PM Summit Therapeutics (SMMT) Tops Q1 EPS by 2c
Apr 28, 2025 07:36AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Apr 28, 2025 05:49AM Summit Therapeutics (SMMT) options active on volume of 49K contracts
Apr 28, 2025 05:35AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Apr 25, 2025 03:00PM Summit Therapeutics (SMMT) to Resume Trading at 3:30 p.m.
Apr 25, 2025 02:52PM Summit Therapeutics (SMMT): Interim OS Analysis Requested from Chinese Health Authorities Shows Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive A
Apr 25, 2025 12:35PM Summit Therapeutics (SMMT) Halted, News Pending
Apr 25, 2025 11:55AM Summit Therapeutics (SMMT) Halted on Volatility, Down 34%
Apr 25, 2025 11:46AM BioNTech SE (BNTX) Hits Low, Down 8%, Summit Therapeutics (SMMT) Falls 18.5%
Apr 25, 2025 09:57AM Increasing unusual put option volume: AZUL BYND SMMT TMC VERU TMUS CHTR SPHR
Apr 24, 2025 07:06AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Apr 23, 2025 09:38AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
Apr 21, 2025 04:25AM Citizens JMP Reiterates Market Outperform Rating on Summit Therapeutics plc (SMMT)
Apr 15, 2025 08:14AM Truist Securities Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Apr 10, 2025 09:09AM Truist Securities Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Apr 10, 2025 06:42AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
Mar 27, 2025 07:42AM Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
Mar 26, 2025 05:01AM Citi Upgrades Summit Therapeutics plc (SMMT) to Buy
Mar 21, 2025 04:16PM Summit Therapeutics (SMMT) grants inducement awards
Mar 21, 2025 08:08AM Cantor Fitzgerald Starts Summit Therapeutics plc (SMMT) at Overweight
Mar 17, 2025 04:24PM Summit Therapeutics (SMMT) appoints Robert LaCaze as CCO
Mar 14, 2025 04:23PM Summit Therapeutics (SMMT) reports inducement grants
Mar 12, 2025 06:25AM Evercore ISI Starts Summit Therapeutics plc (SMMT) at Outperform
Mar 11, 2025 08:55AM Stifel Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Feb 25, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Feb 24, 2025 01:40PM Stifel Reiterates Hold Rating on Summit Therapeutics plc (SMMT)
Feb 24, 2025 07:24AM Summit Therapeutics (SMMT) Announces Clinical Trial Collaboration with Pfizer (PFE) to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)
Feb 24, 2025 06:08AM Summit Therapeutics (SMMT) Tops Q4 EPS by 1c
Jan 21, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Jan 8, 2025 06:06AM Truist Securities Starts Summit Therapeutics plc (SMMT) at Buy
Dec 6, 2024 06:40AM Jefferies Starts Summit Therapeutics plc (SMMT) at Buy
Nov 18, 2024 07:29AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Nov 4, 2024 03:27AM JMP Securities Starts Summit Therapeutics plc (SMMT) at Market Outperform
Oct 31, 2024 06:44AM Summit Therapeutics plc (SMMT) PT Lowered to $44 at H.C. Wainwright
Oct 30, 2024 07:22AM Summit Therapeutics (SMMT) Tops Q3 EPS by 2c
Oct 4, 2024 08:57AM Summit Therapeutics (SMMT): FDA granted Fast Track designation for proposed use of ivonescimab in combination with platinum-based chemotherapy for the treatment of EGFRm NSCLC
Oct 4, 2024 06:36AM H.C. Wainwright Reiterates Buy Rating on Summit Therapeutics plc (SMMT)
Sep 27, 2024 09:49AM Increasing unusual put option volume: ASHR PPL MT SATS SAVA GEHC IONQ SMMT
Sep 27, 2024 05:29AM Citi Downgrades Summit Therapeutics plc (SMMT) to Neutral, 'Valuation Looking Fair for Now'
Sep 27, 2024 05:29AM Citi Downgrades Summit Therapeutics plc (SMMT) to Neutral, 'Valuation Looking Fair for Now'
Sep 25, 2024 07:04AM Summit Therapeutics plc (SMMT) PT Raised to $40 at Stifel
Sep 23, 2024 05:40AM Increasing unusual call option volume: CYH XND LUNR TRU EXC SMMT FWRD FDX GRAB CEG
Sep 17, 2024 05:09AM Increasing unusual option volume: CNM MULN SMAR COMP IMAX SMMT TRU AZUL XLI EMB CARR
Sep 16, 2024 06:55AM Summit Therapeutics plc (SMMT) PT Raised to $45 at H.C. Wainwright
View More Recent Stories View Older Stories